![Pressuring GSK's Advair, Teva launches both AirDuo RespiClick and authorized generic | Fierce Pharma Pressuring GSK's Advair, Teva launches both AirDuo RespiClick and authorized generic | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2017-04/airduo.jpg?VersionId=aa2viWYS6H7jy1q7whcOzhI1Eh58AVb_)
Pressuring GSK's Advair, Teva launches both AirDuo RespiClick and authorized generic | Fierce Pharma
![Mylan's $26 billion hostile bid for West Michigan drugmaker Perrigo fails | Crain's Detroit Business Mylan's $26 billion hostile bid for West Michigan drugmaker Perrigo fails | Crain's Detroit Business](https://s3-prod.crainsdetroit.com/s3fs-public/styles/1200x630/public/NEWS01_151119911_AR_-1_YKVHZSCLDKWK.jpg)
Mylan's $26 billion hostile bid for West Michigan drugmaker Perrigo fails | Crain's Detroit Business
![Price Fixing Lawsuits And Opioid Litigation Shouldn't Deliver A Killing Blow To Teva - 100% Upside (NYSE:TEVA) | Seeking Alpha Price Fixing Lawsuits And Opioid Litigation Shouldn't Deliver A Killing Blow To Teva - 100% Upside (NYSE:TEVA) | Seeking Alpha](https://static.seekingalpha.com/uploads/2019/6/17/saupload_generics-price-fixing.png)
Price Fixing Lawsuits And Opioid Litigation Shouldn't Deliver A Killing Blow To Teva - 100% Upside (NYSE:TEVA) | Seeking Alpha
![Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD](https://www.investors.com/wp-content/uploads/2017/02/IT07-teva-022817-company.jpg)